TipRanks
Advertisement
Advertisement

QNTM Stock Latest News

Quantum BioPharma (NASDAQ: QNTM) Receives FDA Green Light to Move Lucid-MS into Phase 2 Testing
TipRanks NewswireQuantum BioPharma (NASDAQ: QNTM) Receives FDA Green Light to Move Lucid-MS into Phase 2 Testing
6d ago
QNTM
Quantum BioPharma Licensee Unbuzzd Taps New CEO Ahead of Planned Listing
PremiumCompany Announcements
Quantum BioPharma Licensee Unbuzzd Taps New CEO Ahead of Planned Listing
7d ago
QNTM
Quantum BioPharma licensee Unbuzzed Wellness appoints Zapolin as CEO
PremiumThe Fly
Quantum BioPharma licensee Unbuzzed Wellness appoints Zapolin as CEO
7d ago
QNTM
2 Quantum Computing ETFs Analysts Expect to Outperform in 2027
PremiumMarket News
2 Quantum Computing ETFs Analysts Expect to Outperform in 2027
7d ago
IBM
QNT
Quantum BioPharma (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments
PremiumTipRanks Newswire
Quantum BioPharma (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments
8d ago
QNTM
Quantum BioPharma Highlights Year of Financing Moves, Debt Settlement and Governance Changes
PremiumCompany AnnouncementsQuantum BioPharma Highlights Year of Financing Moves, Debt Settlement and Governance Changes
14d ago
6K
QNTM
Quantum BioPharma (NASDAQ: QNTM) Announces that Rodman & Renshaw Initiates Coverage with Buy Rating, $8 Price Target 
Premium
TipRanks Newswire
Quantum BioPharma (NASDAQ: QNTM) Announces that Rodman & Renshaw Initiates Coverage with Buy Rating, $8 Price Target 
14d ago
QNTM
Quantum BioPharma Gains Rodman & Renshaw BUY Rating and US$8 Target
Premium
Company Announcements
Quantum BioPharma Gains Rodman & Renshaw BUY Rating and US$8 Target
14d ago
6K
QNTM
Quantum BioPharma (NASDAQ: QNTM) to Present at 3rd Annual ArcStone-Kingswood Growth Summit 
PremiumTipRanks Newswire
Quantum BioPharma (NASDAQ: QNTM) to Present at 3rd Annual ArcStone-Kingswood Growth Summit 
16d ago
QNTM
Quantum BioPharma Showcases FDA-Backed Lucid-MS Program at Toronto Growth Summit
PremiumCompany Announcements
Quantum BioPharma Showcases FDA-Backed Lucid-MS Program at Toronto Growth Summit
16d ago
6K
QNTM
3 Quantum Computing ETFs With Up to 59% Upside Potential, According to Analysts
PremiumMarket News
3 Quantum Computing ETFs With Up to 59% Upside Potential, According to Analysts
24d ago
IBM
ESTC
Quantum BioPharma to Delist from CSE and Consolidate Trading on Nasdaq
PremiumCompany Announcements
Quantum BioPharma to Delist from CSE and Consolidate Trading on Nasdaq
30d ago
QNTM
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Draws ‘Buy’ Rating on Lucid-MS Potential
PremiumTipRanks NewswireQuantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Draws ‘Buy’ Rating on Lucid-MS Potential
1M ago
QNTM
Quantum Group initiated with a Buy at Rodman & Renshaw
Premium
The Fly
Quantum Group initiated with a Buy at Rodman & Renshaw
1M ago
QNTM
Quantum BioPharma Grants New Stock Options to Support Growth Initiatives
Premium
Company Announcements
Quantum BioPharma Grants New Stock Options to Support Growth Initiatives
1M ago
QNTM
2 Quantum Computing ETFs That Could Climb 44%+, Say Analysts
PremiumMarket News
2 Quantum Computing ETFs That Could Climb 44%+, Say Analysts
1M ago
IONQ
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances Myelin-Protecting MS Therapy as Treatment Paradigm Evolves
PremiumTipRanks Newswire
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances Myelin-Protecting MS Therapy as Treatment Paradigm Evolves
1M ago
QNTM
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reports Lower Q2 Expenses, Advances Lucid-MS Into Phase 2
PremiumTipRanks Newswire
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reports Lower Q2 Expenses, Advances Lucid-MS Into Phase 2
2M ago
QNTM
Quantum BioPharma Boosts Liquidity as FDA Clears Pivotal Lucid-MS Phase 2 Trial
PremiumCompany Announcements
Quantum BioPharma Boosts Liquidity as FDA Clears Pivotal Lucid-MS Phase 2 Trial
2M ago
6K
QNTM
Quantum Biopharma Posts Higher Assets and Losses in Q2 2026 Filing
PremiumCompany AnnouncementsQuantum Biopharma Posts Higher Assets and Losses in Q2 2026 Filing
2M ago
6K
QNTM
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Targets Disability Drivers Beyond Relapse Rates in Multiple Sclerosis
Premium
TipRanks Newswire
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Targets Disability Drivers Beyond Relapse Rates in Multiple Sclerosis
2M ago
QNTM
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Receives FDA Clearance to Advance Lucid-MS Into Phase 2 Multiple Sclerosis Trial
Premium
TipRanks Newswire
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Receives FDA Clearance to Advance Lucid-MS Into Phase 2 Multiple Sclerosis Trial
2M ago
IMUX
QNTM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >